[Effect of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth and remodeling of rat bones during hypokinesia (histomorphometric study)].
The tubular bones of the fore- and hindlimbs of rats immobilized for 5 weeks were examined morphometrically and histologically. The rats were regularly given per os 1,25(OH)2D3, 24,25(OH)2D3 or their combination. The uptake of 24,25(OH)2D3 at a dose of 1.25 micrograms or a combination of 1,25(OH)2D3 and 24,25(OH)2D3 at a dose of 0.03 + 0.25 micrograms led to the recovery of the linear and volume-weight rates of bone formation that changed during hypokinesia. However, these D3 metabolites did not restore the width of the epiphyseal growth plate, whereas the size of the primary and secondary spongiosa returned to normal or exceeded it in response to 24,25(OH)2D3 at a dose of 1.25 micrograms and 1,25(OH)2D3 at a dose of 0.15 micrograms, respectively (only these two doses were used); in other words, the D3 metabolites prevented osteoporosis which is typical of hypokinesia. It is assumed that hypokinesia may produce either disorders in D3 metabolism or changes in the sensitivity of bone cells to active D3 metabolites and other hormones that are directly or indirectly involved in osteogenesis regulation.
D015650:24,25-Dihydroxyvitamin D 3; D000818:Animals; D001846:Bone Development / Q000187:drug effects*; D001842:Bone and Bones / Q000166:cytology; D002117:Calcitriol / Q000494:pharmacology*; D002452:Cell Count; D004100:Dihydroxycholecalciferols / Q000494:pharmacology*; D006132:Growth Plate / Q000187:drug effects; D008297:Male; D009068:Movement; D010006:Osteoblasts / Q000187:drug effects; D010012:Osteogenesis / Q000187:drug effects; D010024:Osteoporosis / Q000517:prevention & control*; D051381:Rats; D011919:Rats, Inbred Strains
D004100:Dihydroxycholecalciferols; D015650:24,25-Dihydroxyvitamin D 3; D002117:Calcitriol
Vliianie 1,25-dioksivitamina D3 i 24,25-dioksivitamina D3 na rost i remodelirovanie kosteĭ krys pri gipokinezii (gistomorfologicheskoe issledovanie).